Insight Molecular Diagnostics (IMDX) Total Debt Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Total Debt Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 5.73% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 10.14% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | -4.73% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 7.07% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 5.11% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -60.49% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -12.66% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -0.64% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 9.58% |
| 10 | Insight Molecular Diagnostics | 172.94 Mn | 144.01 Mn | 15,000.00 | 13.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.41% |
| Dec 31, 2025 | 57.76% |
| Sep 30, 2025 | 113.18% |
| Jun 30, 2025 | 6.28% |
| Mar 31, 2025 | -22.91% |
| Dec 31, 2024 | -45.23% |
| Sep 30, 2024 | -36.64% |
| Dec 31, 2023 | -15.96% |
| Sep 30, 2023 | -70.22% |
| Jun 30, 2023 | -70.16% |
| Mar 31, 2023 | -67.11% |
| Dec 31, 2022 | -61.51% |
| Sep 30, 2022 | -42.62% |
| Jun 30, 2022 | -9.29% |
| Mar 31, 2022 | -0.49% |
| Dec 31, 2021 | -17.23% |
| Sep 30, 2021 | 21.95% |
| Jun 30, 2021 | 63.41% |
| Mar 31, 2021 | 27.89% |
| Dec 31, 2020 | 7.15% |